Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

Tofacitinib is an effective and safe treatment for alopecia areata.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

A child on life support experienced rapid hair loss due to severe illness affecting hair growth.

Zinc deficiency is linked to respiratory infections in children.

Women with PCOS may have a higher risk of respiratory and ear infections due to slower nasal mucociliary clearance.

A woman with Castleman's disease died from respiratory failure due to bronchiolitis obliterans.

People with cleft lip and palate often have respiratory problems.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

After moderate COVID-19, cardiovascular patients had fewer respiratory issues but faced new physical and psychological problems.

Recurrent dry cough, wheezing, and respiratory discomfort are key symptoms for diagnosing pediatric asthma.

Monoclonal antibody B72.3 selectively reacts with certain dog tissues, mainly in the gastrointestinal and respiratory tracts.

Data-driven methods can effectively identify existing drugs for new uses, especially in cancer, infections, and respiratory diseases.

Photobiomodulation helps reduce pain, lessen inflammation, heal wounds, and can be used in skin treatments. It also boosts hair growth in women with hair loss and may help fight microbes and prevent respiratory issues in COVID-19.

During the COVID-19 pandemic in China, skin conditions like eczema and warts increased among children, while respiratory-transmitted skin infections decreased, partly due to mask-wearing.

Certain groups of medications given when leaving the hospital are linked to a higher risk of negative drug reactions within 30 days, especially in older adults with respiratory issues.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

Hair bleach can make rabbit airways more sensitive.

Long COVID causes lasting symptoms and needs ongoing care.

Urban children in western Belarus had more severe COVID-19 cases in 2021.

COVID-19 can cause various skin issues, helping doctors diagnose it early.

Traditional methods may not fully capture how the brain and breathing systems respond to carbon dioxide changes.

Hair loss can happen after severe H1N1 flu but usually grows back in 4 months.